Abstract
The COVID-19 pandemic has led to a rise in cases of Guillain-Barré syndrome (GBS). This autoimmune sequela is a manifestation of the neurotropism potential of the virus. At present, knowledge regarding the pathophysiology, clinical features, management and outcomes of the condition is still evolving. This paper presents the case of a 22-year-old pregnant patient who came in with a history of upper respiratory tract symptoms followed by acroparaesthesia and progressive ascending weakness. She was confirmed to have COVID-19 and GBS and was subsequently managed with intravenous immunoglobulin (IVIg) followed by supportive therapy. To the authors’ knowledge and based on their literature search, this is the first reported case of GBS in a COVID-19 confirmed pregnant patient who received IVIg.
Keywords: neurology; peripheral nerve disease; pregnancy.
【저자키워드】 NEUROLOGY, Pregnancy, peripheral nerve disease, 【초록키워드】 COVID-19, Intravenous immunoglobulin, therapy, knowledge, COVID-19 pandemic, Symptom, outcome, virus, IVIG, Clinical features, Pregnancy, pathophysiology, management, Patient, Autoimmune, upper respiratory tract, pregnant, syndrome, weakness, reported, 【제목키워드】 COVID-19, Pregnancy, Immunoglobulin, syndrome,